Journal article icon

Journal article

Quadrivalent meningococcal conjugate vaccines

Abstract:
Neisseria meningitidis is an important cause of bacterial meningitis and septicaemia with most disease caused by meningococci bearing serogroups A, B, C, Y and W-135 polysaccharides. Monovalent serogroup C conjugate vaccines have become established in the immunisation programmes in many countries and the first quadrivalent meningococcal vaccine, containing the polysaccharides from 4 of the serogroups A, C, Y and W-135 meningococci conjugated to a protein carrier was licensed in the U... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


More by this author
Institution:
"Mater Dei Hospital, Tal-Qroqq, Malta"
Department:
Department of Paediatrics
More by this author
Institution:
University of Oxford
Research group:
Oxford Vaccine Group
Department:
Medical Sciences Division - Clinical Vaccinology and Tropical Medicine,Centre for (CCVTM)
More by this author
Institution:
"National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA"
Department:
Meningitis and Special Pathogens Branch,Division of Bacterial and Mycotic Diseases
Publisher:
Elsevier Publisher's website
Journal:
Vaccine Journal website
Volume:
27
Issue:
Supplement 2
Pages:
B30-B41
Publication date:
2009-06-05
DOI:
ISSN:
0264-410X
URN:
uuid:709e10f4-9bda-49b6-8b29-dc0f74b089c8
Local pid:
ora:3245

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP